Clinicopathologic features of V600E and V600K melanoma--letter
- PMID: 23169438
- PMCID: PMC3605758
- DOI: 10.1158/1078-0432.CCR-12-2974
Clinicopathologic features of V600E and V600K melanoma--letter
Comment on
-
Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.Clin Cancer Res. 2012 Jun 15;18(12):3242-9. doi: 10.1158/1078-0432.CCR-12-0052. Epub 2012 Apr 24. Clin Cancer Res. 2012. PMID: 22535154
References
-
- Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, et al. Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clin Cancer Res. 2012 - PubMed
-
- Edlundh-Rose E, Egyhazi S, Omholt K, Mansson-Brahme E, Platz A, Hansson J, et al. NRAS and BRAF mutations in melanoma tumors in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 2006;16:471–8. - PubMed
-
- Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116:855–67. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA083115/CA/NCI NIH HHS/United States
- C8216/A6129/CRUK_/Cancer Research UK/United Kingdom
- A6129/CRUK_/Cancer Research UK/United Kingdom
- C8216/A8168/CRUK_/Cancer Research UK/United Kingdom
- C588/A10589/CRUK_/Cancer Research UK/United Kingdom
- A10589/CRUK_/Cancer Research UK/United Kingdom
- A8168/CRUK_/Cancer Research UK/United Kingdom
- R01 CA83115/CRUK_/Cancer Research UK/United Kingdom
- G0802123(89696)/MRC_/Medical Research Council/United Kingdom
- R01 CA83115/CA/NCI NIH HHS/United States
- A4994/CRUK_/Cancer Research UK/United Kingdom
- G0802123/MRC_/Medical Research Council/United Kingdom
- 11963/CRUK_/Cancer Research UK/United Kingdom
- C588/A4994/CRUK_/Cancer Research UK/United Kingdom
- 10589/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Medical